WORLD’S FIRST

Hand Carriable CLIA Based COVID-19 Diagnostic Solution


4TH Generation Point-Of-Care Testing – Microfluidic Chemiluminescence


Innovative Technology – Lab-On-A-Chip

Magnetic separation enzymatic chemiluminescence

6 different reagents integrating all in one chip

Unique re-quantitative measuring design

Patented built-in blood filter


Bee Covid_19 Testing MachinesM2 & M5 Chemiluminescence Immunoassay


Focus On Acute Care Applications

Emergency lab/Ambulance/ICU/CCU/Chest pain centre/ Cardiology/Pediatrics

M2 & M5 system enables reducing turnaround time (TAT) significantly.

It perfectly complies with central lab chemiluminescence method & third-party control.

Unique accurate fingertip whole blood PCT perfectly applies to pediatric patients.

9 stepping motors enable complex chemiluminescence reactions on the chip

WORLD’S SMALEST Chemiluminescence Analyzers


M2 Single Channel Chemiluminescence Immunoassay

Machine Details

Hand carriable (4.5kg)

7’ touch screen

Free Maintenance

Enable to connect with LIS/HIS

Built-in GPS, 4G, WIFI, Bluetooth

Thermostat maintains 37C Reaction Environment

Auto calibration & parameter settings via QR code


M5 Four Channels Chemiluminescence Immunoassay

Machine Details

Compact CLIA

4 independent channels

11.6’ foldable touch screen

Free Maintenance

Enable to connect with LIS/HIS

Built-in GPS, 4G, WIFI, Bluetooth

Thermostat maintains 37C Reaction Environment

Auto calibration & parameter settings via QR code


SARS-CoV-2 Ag/Ab/IgG/IgM Diagnostic Test Kit(Microfluidic Chemiluminescence)

Reduce Window Period of Testing

Improve Positive Detection Rates

Minimize Infection Risk


Microfluidic Reagent ChipTest Kit


Completely sealed reaction chips avoid blood sample cross contamination to protect medical professionals.

Test Value

SARS-CoV-2 Ag
A part of virus & earliest biomarker
Direct proof of SARS-CoV-2 infection

SARS-CoV-2 lgM
The first antibody appeared in blood
Detectable in 3-5 days after onset

SARS-CoV-2 IgG
Most abundant part of total antibodies
Enable to be detected most easily

SARS-CoV-2 Total Antibody
Includes IgG, IgM, IgA, IgD and IgE
The most sensitive and earliest Ab indicator


Result Interpretation

Healthy PeopleEarly Stage of COVID-19Middle Stage of COVID-19Recovery Stage of COVID-19
SARS-CoV-2 Ag+/-+/-+/-
SARS-CoV-2 IgM+/-+/-
SARS-CoV-2 IgG+/-+
SARS-CoV-2 Ab+/-++
Ab detections are recommended by Chinese Guidance for COVID-19

Chinese Clinical Guidance for COVID-19 Diagnosis and Treatment (7th edition) 5. Diagnostic criteria

(b) Confirmed cases
Suspected cases with one of the following etiology or serological evidence can be identified as confirmed cases:

(3) The COVID-19 specific IgM and IgM and IgG antibodies are tested positive. The titer of COVID-19 specific IgG antibody is 4 times higher in recovery period than that in acute phase.

9. Identifying cases and filing reports
If COVID-19 nucleic acid tests are negative for two consecutive times (with at least 24 hours interval between each test), and if COVID-19-specific IgM and IgG antibodies remain negative after 7 days from onset, the suspected diagnosis of COVID-19 can be ruled out.


Features

Gold Standard Method
Magnetic separation enzymatic chemiluminescence.

Minisize CLIA Analyzer
Only 4.5kg, Easy to move
Easy access to biosafety cabinet

Safe
Whole blood samples no need centrifugation
Minimize sample exposure to lab environment
Single dose & completely sealed cartridge reduce infection risk

Accurate
High sensitivity & specificity of immunoassay
Avoid high false negative rate of RT-PCR


Rapid
Results in only 15 minutes
No need RNA extraction


3 Easy Steps To Operate


Confidence In PerformanceGolden Standard – Chemiluminescence


Multi-Level Quality Control

Excellent traceability with chemiluminescence

Automatic self-check system

Optic signal calibration chips

3-level liquid QC

External third party QC


Patient Care Management System

Built-in communication modules: GPS, 4G, WIFI, Bluetooth, iCloud
Acute care specialized management software enables locating analyzers, managing operators, online quality control, service support and integrating multiple POC instruments.


Test Menu

PARAMETERSSAMPLE TYPESAMPLE VOLUMETESTING TIME
SARS – CoV- 2 AgSerum, Plasma, Whole blood, Throat Swab, Urine40μl15 mins
SARS – CoV-2 IgG AbSerum, Plasma, Whole blood20μl15 mins
SARS-CoV-2 IgM AbSerum, Plasma, Whole blood20μl15 mins
SARS – CoV-2 AbSerum, Plasma, Whole blood20μl15 mins

Specification

CHEMILUMINESCENCE ANALYZERS

Model No.M2M5
Dimension267.5mm x 180 mm x 220mm290mm x 229mm x 350mm
Weight4.5kg10kg
KW300VA250VA
Input PowerAC 100V-240V 50/60HzAC 100V-240V 50/60Hz

MICROFLUIDIC REAGENT CHIP

Testing Time10-15min/test
Sample TypeWhole blood/ peripheral blood/ plasma/ serum
Sample Volume5-50μl

Intellectual Property

TYPEGRANTEDISSUEDUPCOMING APPLICATIONS
Invention17188
Utility Model221511
Software Copyright521
Trademark4//
PTC/63
Total554029